☆ 4.7 Meeting Abstract

Efficacy and safety of abrocitinib in biologic-exposed versus biologic-naive patients with moderate-to-severe atopic dermatitis

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Journal

JOURNAL OF INVESTIGATIVE DERMATOLOGY

Volume 142, Issue 8, Pages S53-S53

Publisher

ELSEVIER SCIENCE INC

Keywords

-

Categories

Dermatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.